Metraipolis › archive › dc_79bd7c82f26d

Using causal machine learning and real world data to improve dose response decision making for secukinumab in psoriatic arthritis — Europe PMC PMID:41965445

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41965445
DOI
10.1038/s41598-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-10-06T18:04:44.919Z
SHA-256 of the archived text
53d3a9709f59099d2d38a9bebd0435149f898fac4cf08b93d0528074be72295e
Stable URL of this page
https://metraipolis.com/documento/dc_79bd7c82f26d

How to cite

Using causal machine learning and real world data to improve dose response decision making for secukinumab in psoriatic arthritis — Europe PMC PMID:41965445 — Europe PMC (en), https://europepmc.org/article/MED/41965445 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_79bd7c82f26d (Metraipolis archive dc_79bd7c82f26d, sha256 53d3a9709f59099d2d38a9bebd0435149f898fac4cf08b93d0528074be72295e)
BibTeX
@misc{dc79bd7c82f26d,
  title = {Using causal machine learning and real world data to improve dose response decision making for secukinumab in psoriatic arthritis — Europe PMC PMID:41965445},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41965445},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_79bd7c82f26d; sha256 53d3a9709f59099d2d38a9bebd0435149f898fac4cf08b93d0528074be72295e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41965445. Agents can read the archived copy with the MCP tool read_document.